We have located links that may give you full text access.
Integrase inhibitor MK-0518: Merck opens expanded-access program.
AIDS Treatment News 2006 July
Patients resistant to at least one drug in all three oral classes may qualify for this new kind of antiretroviral--which still must be combined with other active drugs.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app